STEROID REFRACTORY GRAFT VERSUS HOST DISEASE
Clinical trials for STEROID REFRACTORY GRAFT VERSUS HOST DISEASE explained in plain language.
Never miss a new study
Get alerted when new STEROID REFRACTORY GRAFT VERSUS HOST DISEASE trials appear
Sign up with your email to follow new studies for STEROID REFRACTORY GRAFT VERSUS HOST DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a rheumatoid arthritis drug tame chronic GVHD and cut steroid use?
Disease control OngoingThis trial tests leflunomide, a drug used for rheumatoid arthritis, in people with chronic graft-versus-host disease (cGVHD) who depend on steroids. cGVHD is a complication of bone marrow transplant where donor immune cells attack the recipient's body. The goal is to see if leflu…
Matched conditions: STEROID REFRACTORY GRAFT VERSUS HOST DISEASE
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Engineered immune cells aim to tame chronic GVHD
Disease control TerminatedThis early-phase study tests a new treatment called CD6-CAR Tregs for people with chronic graft-versus-host disease (cGVHD), a complication after a stem cell transplant. The treatment uses specially engineered immune cells from a donor to help control the immune attack on the pat…
Matched conditions: STEROID REFRACTORY GRAFT VERSUS HOST DISEASE
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC